Feb 5 Cardiology News Podcast

For This Week in Cardiology Feb, 5, 2016, Dr John Mandrola comments on the following cardiology news and features stories:

• Validity of Pivotal ROCKET AF Rivaroxaban Trial Questioned

• Califf for Commish? Threatened Filibuster and 'Holds' Rock Confirmation Process

• Early Invasive ACS Strategy Best in 'After 80' Very Elderly

• Early Invasive NSTEMI Strategy: Fewer MIs in Small Trial

• Post–Cardiac-Surgery Hyperglycemia: Not One Size Fits All

• Telemetry Ward Suffices for Stable Non-ST-Elevation ACS in Analysis

Chief Cardiology Correspondent

John M Mandrola, MD, Clinical Electrophysiologist, Baptist Medical Associates, Louisville, Kentucky

John M Mandrola, MD has disclosed the following relevant financial relationships:
Served as a speaker or member of a speaker's bureau for Medtronic.

© 2016  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Feb 5 Cardiology News Podcast - Medscape - Feb 05, 2016.